| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
286.01(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,279,317 |
| Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$207,372,438 |
| Total People Sold |
9 |
9 |
9 |
14 |
| Total Sell Transactions |
10 |
11 |
13 |
34 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schumacher Laura J |
Vice Chairman |
• – – |
2020-02-28 |
4 |
D |
$85.42 |
$2,882,498 |
D/D |
(33,745) |
206,901 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2020-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,675 |
523,561 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
58,781 |
104,544 |
|
- |
|
| Stewart Jeffrey Ryan |
SVP, US Commercial Operations |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
21,896 |
85,487 |
|
- |
|
| Michael Robert A. |
EVP, Chief Financial Officer |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,795 |
27,708 |
|
- |
|
| Alban Carlos |
Vice Chairman |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
72,439 |
200,316 |
|
- |
|
| Durkin Brian L |
VP, Controller |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,527 |
15,035 |
|
- |
|
| Richmond Timothy J. |
EVP, Chief HR Officer |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
34,907 |
34,907 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
200,262 |
527,236 |
|
- |
|
| Donoghoe Nicholas |
SVP, Enterprise Innovation |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,316 |
17,504 |
|
- |
|
| Severino Michael |
Vice Chairman |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
75,595 |
191,452 |
|
- |
|
| Saleki-Gerhardt Azita |
EVP, Operations |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
36,897 |
130,209 |
|
- |
|
| Schumacher Laura J |
Vice Chairman |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
76,166 |
240,646 |
|
- |
|
| Hudson Thomas J |
SVP, R&D and CSO |
• – – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,372 |
25,120 |
|
- |
|
| Donoghoe Nicholas |
SVP, Enterprise Innovation |
• – – |
2020-01-02 |
4 |
D |
$88.54 |
$79,863 |
D/D |
(902) |
12,188 |
|
- |
|
| Stewart Jeffrey Ryan |
SVP, US Commercial Operations |
• – – |
2019-12-10 |
4 |
D |
$86.44 |
$148,072 |
D/D |
(1,713) |
63,591 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2019-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
326,974 |
|
- |
|
| Schumacher Laura J |
Vice Chairman |
• – – |
2019-11-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
358 |
164,480 |
|
- |
|
| Richmond Timothy J. |
EVP, Chief HR Officer |
• – – |
2019-09-27 |
4 |
S |
$75.02 |
$1,163,873 |
D/D |
(15,515) |
0 |
|
- |
|
| Schumacher Laura J |
Vice Chairman |
• – – |
2019-09-16 |
4 |
B |
$70.42 |
$1,760,523 |
D/D |
25,000 |
164,838 |
2.74 |
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2019-09-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,010 |
335,155 |
|
- |
|
| Donoghoe Nicholas |
SVP, Enterprise Innovation |
• – – |
2019-08-29 |
4 |
B |
$66.19 |
$498,057 |
D/D |
7,525 |
13,090 |
2.74 |
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2019-08-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,050 |
350,165 |
|
- |
|
| Stewart Jeffrey Ryan |
SVP, US Commercial Operations |
• – – |
2019-08-16 |
4 |
B |
$64.44 |
$1,002,169 |
D/D |
15,552 |
65,304 |
2.74 |
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2019-08-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
30,000 |
|
- |
|
641 Records found
|
|
Page 14 of 26 |
|
|
0.31 (0.19%) 
